Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT07272772
Overview
The objective of this prospective study is to evaluate diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer. The aim is to evaluate the sensitivity and specificity of 18F-FAPI-74 in detection of local lymph node metastasis and distant metastasis in patient level in patients with colon cancer in primary staging and when suspected recurrence. 100 patients with colon cancer are enrolled and PET/CT studies are performed with the novel 18F-FAPI-74 tracer. The data will be collected between 2024-2026.
Sponsor
Turku University Hospital
Phase
Phase 2/3
Contacts
Saila Kauhanen
saila.kauhanen@utu.fi
+358503017010
ClinicalTrials.gov
NCT07272772Drug / Compound
Help us improve your experience